General MedicationsINJECTIONStandard
MEGATOPE
ALBUMIN IODINATED I-131 SERUM
Standard Dose
0.5mCi/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MEGATOPE is listed in Drugs@FDA under application 017837 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ALBUMIN IODINATED I-131 SERUM Form and strength INJECTABLE;INJECTION - 0.5mCi/VIAL Sponsor ISO TEX Submission history Latest submission status date: 2023-08-25 00:00:00.
Structured Monograph
Clinical summary
Approval overview MEGATOPE is listed in Drugs@FDA under application 017837 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ALBUMIN IODINATED I-131 SERUM Form and strength INJECTABLE;INJECTION - 0.5mCi/VIAL Sponsor ISO TEX Submission history Latest submission status date: 2023-08-25 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.